David Shaw’s Arvinas ARVN Stock Holding History

David Shaw’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,500	Closed	-$781K	–	5377
2021 Q3	$781K	Hold	9,500	–	–	﹤0.01%	3786
2021 Q2	$732K	Buy	+9,500	New	+$659K	﹤0.01%	3795

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

David Shaw's ARVN Position: Q2 2026 in Review

David Shaw reduced its Arvinas (ARVN) stake by 3.9% in Q2 2026, selling an estimated $1.34M and leaving 3,495,153 shares worth $29M. The position accounts for 0.01% of the portfolio, ranked #1056.

David Shaw first reported a position in ARVN in Q4 2019 and has held it in 22 quarters since. The position peaked at $43.8M in Q4 2025. 199 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

David Shaw held 3,495,153 shares of Arvinas worth $29M as of Q2 2026.
David Shaw sold 143,414 Arvinas shares in Q2 2026, an estimated $1.34M.
Arvinas made up 0.01% of David Shaw's portfolio in Q2 2026, its #1056 holding.
David Shaw first reported a position in Arvinas in Q4 2019 and has held it in 22 quarters since.
David Shaw's Arvinas position peaked at $43.8M in Q4 2025.
199 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.